AU2002306918A1 - Methods of modulating angiogenesis - Google Patents

Methods of modulating angiogenesis

Info

Publication number
AU2002306918A1
AU2002306918A1 AU2002306918A AU2002306918A AU2002306918A1 AU 2002306918 A1 AU2002306918 A1 AU 2002306918A1 AU 2002306918 A AU2002306918 A AU 2002306918A AU 2002306918 A AU2002306918 A AU 2002306918A AU 2002306918 A1 AU2002306918 A1 AU 2002306918A1
Authority
AU
Australia
Prior art keywords
methods
modulating angiogenesis
angiogenesis
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002306918A
Inventor
George Liang King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joslin Diabetes Center Inc
Original Assignee
Joslin Diabetes Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joslin Diabetes Center Inc filed Critical Joslin Diabetes Center Inc
Publication of AU2002306918A1 publication Critical patent/AU2002306918A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11013—Protein kinase C (2.7.11.13)
AU2002306918A 2001-03-27 2002-03-27 Methods of modulating angiogenesis Abandoned AU2002306918A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27908301P 2001-03-27 2001-03-27
US60/279,083 2001-03-27
PCT/US2002/009509 WO2002077198A2 (en) 2001-03-27 2002-03-27 Methods of modulating angiogenesis

Publications (1)

Publication Number Publication Date
AU2002306918A1 true AU2002306918A1 (en) 2002-10-08

Family

ID=23067564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002306918A Abandoned AU2002306918A1 (en) 2001-03-27 2002-03-27 Methods of modulating angiogenesis

Country Status (3)

Country Link
US (2) US20020165158A1 (en)
AU (1) AU2002306918A1 (en)
WO (1) WO2002077198A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030157573A1 (en) * 2002-02-12 2003-08-21 Orna Mor Use of Axl receptor for diagnosis and treatment of renal disease
AUPS078002A0 (en) * 2002-02-27 2002-03-21 Unisearch Limited Dnazyme therapeutics
WO2003087367A2 (en) * 2002-04-18 2003-10-23 Lynkeus Biotech Gmbh Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
US20040175384A1 (en) * 2003-12-12 2004-09-09 Mohapatra Shyam S. Protein kinase C as a target for the treatment of respiratory syncytial virus
US8592368B2 (en) 2003-12-19 2013-11-26 University Of South Florida JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection
CN105251024A (en) * 2004-08-23 2016-01-20 西伦蒂斯私人股份公司 Treatment of eye disorders
GB0521351D0 (en) * 2005-10-20 2005-11-30 Genomica Sau Modulation of TRPV expression levels
GB0521716D0 (en) * 2005-10-25 2005-11-30 Genomica Sau Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases
US20090130212A1 (en) * 2006-05-15 2009-05-21 Physical Pharmaceutica, Llc Composition and improved method for preparation of small particles
ES2390499T3 (en) * 2006-06-12 2012-11-13 Opko Pharmaceuticals, Llc Compositions and methods for inhibition of angiogenesis by sirna
US7872118B2 (en) * 2006-09-08 2011-01-18 Opko Ophthalmics, Llc siRNA and methods of manufacture
AU2007356036A1 (en) * 2007-06-29 2009-01-08 Newsouth Innovations Pty Limited Treatment of rheumatoid arthritis
SG171952A1 (en) 2008-12-04 2011-07-28 Opko Ophthalmics Llc Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
MX2011010041A (en) 2009-04-01 2011-11-18 Danisco Us Inc Compositions and methods comprising alpha-amylase variants with altered properties.
BR112015004452A2 (en) 2012-09-05 2017-08-08 Sylentis Sau sirna and its use in methods and compositions for the treatment and / or prevention of eye conditions
GB201215857D0 (en) 2012-09-05 2012-10-24 Sylentis Sau siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
US10011837B2 (en) 2014-03-04 2018-07-03 Sylentis Sau SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61758B1 (en) * 1986-05-23 1994-11-30 Daiichi Seiyaku Co Use of a sulfated polysaccharide
US5654273A (en) * 1994-09-22 1997-08-05 Children's Medical Center Corporation Synducin mediated modulation of tissue repair
UA54427C2 (en) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Method for treating eye diseases caused by vascular endotelium growth factor
US20020048582A1 (en) * 2000-07-18 2002-04-25 King George L. Methods of modulating angiogenesis

Also Published As

Publication number Publication date
WO2002077198A8 (en) 2003-08-21
US20080038245A1 (en) 2008-02-14
US20020165158A1 (en) 2002-11-07
WO2002077198A2 (en) 2002-10-03
WO2002077198A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
AU2002310593A1 (en) Laser parrering of devices
AU2002363005A1 (en) Derivatives of uk-2a
AU2002306918A1 (en) Methods of modulating angiogenesis
AU2003286746A1 (en) Modulators of angiogenesis and tumorigenesis
AU2001291019A1 (en) Method of modulating neovascularization
AU2003234613A1 (en) Method of modulating angiogenesis
AU2003270066A1 (en) Modulators of angiogenesis
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2002320525A1 (en) Antisense modulation of glioma-associated oncogene-2 expression
AU2002366788A1 (en) Antisense modulation of ship-1 expression
AU2003224712A1 (en) Modulating angiogenesis
AU2002318139A1 (en) Antisense modulation of src-c expression
AU2002357102A1 (en) Antisense modulation of cd36l1 expression
AU2001280588A1 (en) Methods of modulating angiogenesis
AU2001271426A1 (en) Modulation of apoptosis
AU2002361763A1 (en) Method of reducing angiogenesis
AU2002307413A1 (en) Modulators of angiogenesis
AU2002347809A1 (en) Antisense modulation of inhibitor-kappa b kinase-gamma expression
AU2003217229A1 (en) Methods of modulating angiogenesis
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002329838A1 (en) Modulation of appl expression
AU2002348191A1 (en) Method and composition for the modulation of angiogenesis
AU2002304733A1 (en) Amino-aza-cyclohexanes for the treatment of malaria
AU2002315554A1 (en) Antisense modulation of glioma-associated oncogene-3 expression
AU2003214220A1 (en) Caspr3: modulators of angiogenesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase